Globalization of stem cell science: an examination of current and past collaborative research networks by Ouzounis, Christos A. et al.
  
Ouzounis, Christos A., Luo, Jingyuan and Matthews, 
Kirstin R. W. 
 
Globalization of stem cell science: an 
examination of current and past 
collaborative research networks 
Article (Accepted version) 
(Refereed) 
 
 
 
Original citation: 
Ouzounis, Christos A., Luo, Jingyuan and Matthews, Kirstin R. W. (2013) Globalization of stem 
cell science: an examination of current and past collaborative research networks. PLOS One, 8 
(9). ISSN 1932-6203 
 
DOI: 10.1371/journal.pone.0073598 
 
© 2013 The Authors © CC-BY-3.0  
 
This version available at: http://eprints.lse.ac.uk/54898/ 
Available in LSE Research Online: April 2014 
 
LSE has developed LSE Research Online so that users may access research output of the 
School. Copyright © and Moral Rights for the papers on this site are retained by the individual 
authors and/or other copyright owners. Users may download and/or print one copy of any 
article(s) in LSE Research Online to facilitate their private study or for non-commercial research. 
You may not engage in further distribution of the material or use it for any profit-making activities 
or any commercial gain. You may freely distribute the URL (http://eprints.lse.ac.uk) of the LSE 
Research Online website.  
 
This document is the author’s final accepted version of the journal article. There may be 
differences between this version and the published version.  You are advised to consult the 
publisher’s version if you wish to cite from it. 
 
 
 
Globalization of Stem Cell Science: An Examination of
Current and Past Collaborative Research Networks
Jingyuan Luo1,2, Kirstin R. W. Matthews2*
1Department of Law, London School of Economics and Political Science, London, United Kingdom, 2 Science and Technology Policy Program, James A. Baker III Institute
for Public Policy, Rice University, Houston, Texas, United States of America
Abstract
Science and engineering research has becoming an increasingly international phenomenon. Traditional bibliometric studies
have not captured the evolution of collaborative partnerships between countries, particularly in emerging technologies
such as stem cell science, in which an immense amount of investment has been made in the past decade. Analyzing over
2,800 articles from the top journals that include stem cell research in their publications, this study demonstrates the
globalization of stem cell science. From 2000 to 2010, international collaborations increased from 20.9% to 36% of all stem
cell publications analyzed. The United States remains the most prolific and the most dominant country in the field in terms
of publications in high impact journals. But Asian countries, particularly China are steadily gaining ground. Exhibiting the
largest relative growth, the percent of Chinese-authored stem cell papers grew more than ten-fold, while the percent of
Chinese-authored international papers increased over seven times from 2000 to 2010. And while the percent of total stem
cell publications exhibited modest growth for European countries, the percent of international publications increased more
substantially, particularly in the United Kingdom. Overall, the data indicated that traditional networks of collaboration extant
in 2000 still predominate in stem cell science. Although more nations are becoming involved in international collaborations
and undertaking stem cell research, many of these efforts, with the exception of those in certain Asian countries, have yet to
translate into publications in high impact journals.
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Introduction
Science and engineering (S&E) research is becoming increas-
ingly globalized. Advances in communication and technology now
permit the scientific community to share data and publications
within minutes. According to the US National Science and
Engineering Indicators, from 1995 to 2010, the number of
internationally co-authored publications in the physical, natural,
and social sciences more than doubled from 79,128 to 185,303
publications [1].
Previous scholarship demonstrated that multi-institutional
collaborations increase citation rates, and publications resulting
from international collaborations garner twice as many citations as
those produced by scientists working at a single institution or
within a single country [2–5]. This is also true within the subfield
of stem cell research [6–7]. There are many possible explanations
for this phenomenon. Collaboration can be beneficial through the
sharing of resources, ideas, and expertise. It also provides younger
researchers and labs more exposure in the international arena,
affording them better networking opportunities within the research
community.
When the overall S&E publications were reviewed, 43% of
internationally co-authored publications involved US-based re-
searchers in 2010, while researchers from Germany and the
United Kingdom were second and third with 19% each [1]. This
is congruent with the strong S&E cultures in these three countries.
Historically, factors such as geographic proximity, availability of
funding for research, language, and even cultural practices relating
to work, research, and data-sharing ethics, have played prominent
roles in a researcher’s decision to collaborate [8–10]. Shared
histories, such as the colonial connection between the United
Kingdom and the United States, as well as membership in
supranational organizations like the European Union, have also
influenced the decision to collaborate. Moreover similar national
legal infrastructures pertaining to intellectual property rights,
similar political ideologies, and educational exchange/scholarship
programs may also impact one’s decision to enter into collabo-
rations. The worldwide research environment, however, is
changing. S&E expenditures have increased an average of seven
percent annually over the past decade [11]. Much of the growth is
coming from China, India, and other developing nations and their
governments, which are placing increased emphasis on S&E
research to help improve economic growth, employment, and
social well-being.
The effects of emerging nations’ presence in the international
research environment, however, still remain to be examined.
Traditional bibliometric analyses have evaluated research trends
by country, institute, journal, and field of study [12]. Recently,
more attention has been shifted towards studying networks of co-
authorship and their effects on publication citation rates [13,14].
No study, however, has captured the evolution of collaborative
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partnerships between countries and the changing research
networks worldwide. This study, thus, seeks to examine the extant
research networks in S&E and how they have developed in the
past decade using stem cell science as the area of study.
Stem cell science is a particularly interesting field for a study of
international collaborations. Stem cells are undifferentiated cells
with the capability for self-renewal and can give rise to a vast array
of tissue or organ-specific cells [15]. There are primarily three
types of stem cells with varying degrees of differentiation potential:
adult stem cells (ASCs), embryonic stem cells (ESCs), and induced
pluripotent stem cells (iPSCs). They can be isolated from the
embryo (blastocyst) five to six days post-fertilization (ESCs) and
from several adult organs (ASCs) [14]. The third class, iPSCs, are
generated by reverting adult somatic cells back to a state
resembling ESCs by turning on genes associated with this
embryonic state [16].
Stem cell research – embryonic, adult, and induced pluripotent
– has been identified as one of the most important areas in
biomedical research today [12]. It is an emerging area of research,
exhibiting rapid growth in the number of publications and patents
annually. It is also an area with an intrinsic international nature.
Laboratories from 50 different countries have published papers in
this area in the past five years [17]. Furthermore, various
international organizations–such as the International Society for
Stem Cell Research (www.isscr.org), the International Stem Cell
Forum (www.stem-cell-forum.net), and the International Consor-
tium of Stem Cell Networks (www.stemcellconsortium.org)–have
been established to facilitate the exchange of scientific and policy
knowledge. These international organizations were founded while
the field of stem cell science was young, thus presenting the
opportunity to study collaborative partnerships in a field that was
characterized, at its nascence, by high levels of international
collaborations.
Finally, because of the controversial nature of stem cell science,
more specifically research with human ESCs as well as clinical trial
safety issues arising from ASC and potential iPSC therapies,
research is currently being conducted under varying policy
regimes. Many established, leading nations in biomedical research,
such as the United States, the United Kingdom, and Germany,
have very disparate policies towards human ESC research. US
researchers face a policy regime that is constantly under flux. Until
President Barack Obama’s executive order in 2009, the federal
government only funded projects limited to human ESC lines
created before August 2001, the result of President George W.
Bush’s policy [18,19]. In contrast, the United Kingdom employs a
more permissive but highly regulated approach towards stem cell
research through the Human Fertilisation and Embryology
Authority (HFEA), which operates a strict licensing regime for
stem cell lines [20]. And while human ESC lines can be derived in
both the United States and United Kingdom, Germany’s stem cell
research policy bans their production entirely. However, it does
allow the importation and use of cell lines created before May 1,
2007 (previously January 1, 2002) [21,22].
The highly regulated and sometimes restrictive stem cell
research environment in these nations is a stark contrast to the
permissive policies in many developing nations, such as China,
who has recently bolstered their S&E research infrastructure [23].
China permits both the derivation of human ESC lines as well as
the use of therapeutic cloning [24]. Additionally, many purported
stem cell therapies are currently being offered in Chinese clinics
[25]. Stem cell science, thus, presents a unique opportunity not
only to study international collaborative research networks, but
also the evolution of these networks under disparate policy
regimes.
While it is generally accepted that science is becoming
increasingly international, little research has been done to examine
the exact nature of this globalization. By mapping collaborative
partnerships by country, this research sought to compare the
current research networks in stem cell science with networks
present a decade ago, with the goal of characterizing the
globalization of research in this field.
This study analyzed 2,814 publications from the top 50 journals
by impact factor in 2000 and 2010 that publish stem cell research.
Data revealed that international publications increased from
20.9% (203 of 969) in 2000 to 36% (664 of 1845) in 2010. The
United States remains the most prolific and dominant country,
with authorship on nearly 60% of all the papers analyzed in both
2000 and 2010. Asian countries, however, are steadily increasingly
their shares of articles in top journals. Chinese stem cell
publications increased from 0.41% in 2000 to 4.61% in 2010.
The data also indicated that traditional networks of collaborations,
those that were prominent in 2000 remain so in 2010, despite
persistent differences in national stem cell policies and an
increased number of countries involved in stem cell research.
And although there was evidence of an increasing number of
nations becoming involved in international collaborations and
undertaking stem cell research, many of these national efforts, with
the exception of certain Asian countries, have yet to translate into
publications in high impact journals.
Methods
To map collaborative partnerships in stem cell research, a
bibliometric analysis of publications was performed. Publications
were retrieved from Thomson Reuters’ Institute of Scientific
Information (ISI) Science Citation Index (Web of Science). This
database was chosen for its comprehensive collection of peer-
reviewed publications and its use in many prior bibliometric
studies [12,26]. It is also the leading source of bibliometric
information, as it indexes quality, peer-reviewed journals and has
international, multidisciplinary coverage [27].
Only English-language articles were selected so the abstracts of
the articles could be reviewed quickly to ensure that each article
truly pertained to stem cell research. A preliminary analysis of
retrieved ISI publications indicated that well over 95% of the
papers published annually are in English, thus allowing the study
to capture the majority of collaborative partnerships.
Stem cell research articles from two years 2000 and 2010 were
identified by entering the search string: TS= (‘‘stem cell’’). Only
research articles were selected, filtering out book chapters,
proceedings papers, and books. The year 2010 was selected, as
it was the most recent full year for which stem cell publications
could be retrieved when the study was initiated. The year 2000
was selected because it followed shortly after Dr. James Thomson
and his colleagues at the University of Wisconsin-Madison
successfully derived the first human ESC line, a major break-
through in stem cell research and impetus for further research in
the area [28]. Additionally, selecting the year 2000 as a time point
allowed for the examination of a decade of development in stem
cell research. To confirm the years 2000 and 2010 were
representative of the general pool of stem cell publications, a
preliminary examination of the top 50 countries with the most
stem cell publications from 1990–2010 was conducted and yielded
no immediate anomalies from either 2000 or 2010.
Running a search with the above parameters in ISI yielded
3,861 stem cell articles for 2000 and 14,974 articles for 2010, a
nearly four-fold increase. After identifying the top 50 journals for
2000 and 2010 by impact factors for the respective years, all stem
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cell related scientific publications from these journals were selected
for further analysis (Table S1 and S2). While impact factor is only
one of a number of measurements that reflect the quality and
eminence of a journal, it is the most commonly used and accepted
in academia [29]. Selecting papers only from the top 50 journals
could skew the data towards countries with more established
traditions of S&E research. However, analyzing publications from
top journals ensured that high quality research endeavors were
studied, as these journals typically employ rigorous peer-reviewing
mechanisms during their publication processes. Moreover, articles
published in high impact journals are more likely to be circulated
among researchers internationally and possess a greater impact on
future research. Analyzing the publications with the most influence
on the direction of global research and the development of
therapeutics can reveal whether stem cell research has truly
globalized. And as these publications are often the result of
prominent research networks, the analysis will indicate whether
the most influential research networks have evolved as a result of
the increasing number of nations participating in stem cell
research, or if these networks have remained relatively largely
unaltered. The impact factor of journals was also utilized in lieu of
other measurements of publication quality such as the citation rate
of individual papers because the citation rate for an article is more
dynamic, whereas journal impact factors remain relatively
constant over time [30]. Admittedly, in a field undergoing rapid
growth such as stem cell science, journal impact factors are likely
to experience greater changes, which were taken into account
during data collection and in its analysis.
The top 50 journals were identified through a comparison of the
top 300 Thomson Reuters’s Journal Citation Reports (JCR) for
2000 and 2010 with the corresponding journals for each year in
which stem cell articles were published (Table S1 and S2). Of the
14,974 papers located from 2010, 1,845 were analyzed. Of the
3,861 papers identified from 2000, 969 were analyzed.
In order to gauge the extent of any shifts in the proportion of
stem cell types used in research and the possible bias this may
contribute to the network analysis, keywords for all the papers
were analyzed as a crude examination of content change. More
exhaustive analysis is needed in the future to precisely quantify any
content changes and correlate these changes with potential biases.
In total, over 24,000 keywords were analyzed from both 2000 and
2010, the majority of which were unrelated to the specific stem
cells types – embryonic, adult, induced pluripotent, and cancer –
identified as distinct major areas of stem cell research. Each article
had multiple keywords, with no consistency in the format of the
keywords, resulting in each type of stem cell being denoted by an
array of keywords. For embryonic stem cells, keywords included
embryonic stem-cell(s), embryonic stem cell(s), human embryonic
stem cell, and human ESC amongst others. Specific keywords
were chosen such that they only corresponded to one of the
aforementioned four types of stem cells (see Table 1 for the exact
terms searched for each type of stem cell). A search for terms
connected to stem cell research in general was also conducted as a
control. This search encompassed all of the keywords used for the
four specific cell types as well as the terms self-renewal,
pluripotent(cy), and differentiation, which apply to stem cells in
general but cannot be used to identify specific types.
There are several methods for counting collaborations, many of
which, including the fractional counting method, do not apply well
to examining collaborations between countries, as they provide a
numerical measurement of collaboration but do not indicate
network relationships [9]. For this study, the collaborations were
noted, with the country affiliation of the corresponding author(s)
demarcated with an asterisk after the country name at the first
level of analysis. This is because corresponding authors typically
have a greater role in leading and funding the research project,
thus a theoretically greater role in the collaboration. From this, the
reoccurring two-way, three-way, four-way, etc. collaborations
were recorded.
Next, partnerships were examined by recording each publica-
tion as a set of pairings. Publications with four countries, for
instance, would result in six different pairings. Following this, the
tendency of two nations to collaborate was determined by
calculating a ratio of the observed to expected co-authorship
frequency [10]. The following formula was used to calculate
observed to expected ratio (Er) for each set of countries:
Er~
Cx,yT
CxCy
  
{1
where
Cx= total number of collaborations for country X
Cy= total number of collaborations for country Y
Cx,y = total number of collaborations between country X and
country Y
T= total number of collaborations in a group of countries
The value of the ratio, then, is an indication of country X and
Y’s propensity to collaborate with each other. The results of the
formula depend not only on the two countries for which the ratio
is calculated, but also on the presence of the other nations in the
group. The ratio, thus, does not describe an exact relationship
between country X and Y, rather, it illustrates tendency of the two
countries to collaborate within a specific group of nations. In this
study, the specific group of nations refers to those (35 for 2000 and
47 for 2010) that participated in international publications. The
value used for T was the total number of partnerships in which
Table 1. Stem cell publications keyword analysis.
2000 2010
Keywords** Keywords
Adult Stem Cells 8.1% 6.3%
Embryonic Stem Cells 1.7% 1.6%
Induced Pluripotent
Stem Cells
0% 0.18%
Cancer Stem Cells 3.6% 5.9%
Stem Cells 17.0% 19.0%
*The areas of research and their corresponding keywords are as follows: ‘‘Adult
Stem Cells’’ (Bone marrow; Marrow; Hematopoietic; Endothelial cell(s); Liver;
Umbilical; Cardiomyocyte; Cardiac; Central-nervous-system; Epithelial-cell(s);
Erythropoeisis; Hematopoiesis; Hematopoietic-stem; Hematopoietic stem-cell;
Neuron; Progenitor),’’Embryonic Stem Cells’’ (Embryo(s); Embryonic; Embryonic
stem-cell; Embryonic-development; Embryogenesis; ES-cell(s); Human
embryonic stem), ‘‘Induced Pluripotent Stem Cells’’ (IPS Cell(s)), and ‘‘Cancer
Stem Cells’’ (Myeloid-Leukemia; Leukemia; Cancer; Chemotherapy: Tumor;
Breast cancer; BCR-ABL; Myelogenous; Carcinoma; Chronic-myeloid leukemia;
CML).
**Percentages are low due to the large number of keywords (15,526 for 2010
and 9,271 for 2000) analyzed, many of which do not specifically refer to a type
of stem cell. The general stem cells category serves as a control, indicating that
the percentage of keywords explicitly referring to stem cells is low and remains
a relatively constant proportion of total keywords.
15,526 and 9,271 keywords were associated with articles analyzed in 2010 and
2000, respectively. Categories of stem cell research and corresponding
keywords were used to analyze any potential shifts in research areas from 2000
to 2010. Specific keywords were chosen such that they only correspond to one
type of stem cell.*
doi:10.1371/journal.pone.0073598.t001
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these nations participated, 426 for 2000 and 1850 for 2010. Two
different manners of examining the data were utilized. One
examined the prevalent collaborations (two or more countries, one
of which is a corresponding author). The second focused on
partnerships (two countries, one of which can be but is not
necessarily a corresponding author). The resulting data for the two
look similar because the top collaborations also happened to be
partnerships. For the remainder of the paper, the words
collaboration and partnership will be used to help differentiate
these two manners of data analysis. All the above patterns were
then examined in the context of each nation’s policies towards
stem cell research.
Results
Of the 969 publications analyzed from the year 2000, 203 of the
papers (20.9%) were international publications involving two or
more countries (Table 2). In 2010 this percentage significantly
increased to 36.0%, 662 of 1845 publications, (p,0.01; two tailed,
paired t-test comparing the percent of international collaborations
by country for 2000 and 2010). The number of countries
represented grew from 35 in 2000 to 47 in 2010.
It is important to note that there are some differences between
the two sets of journals for 2000 and 2010, as many journals
prominent in 2010 were not yet in existence in 2000 (Table S1 and
S2). Of the top 50 journals for both years, 26 journals are present
are both lists, 20 journals in 2010 did not publish stem cell
research in 2000 or were not in existence, and 4 journals on the
2010 list did not have high enough impact factors in 2000 to make
the top 50 list. These differences are likely due to the large growth
that stem cell research experienced from 2000 to 2010, as well as
the growth of scientific journals overall. And on average, the
journal impact factors were higher for 2010, at 15.77 versus 11.37
for 2000, possibly indicating an increase in the prominence of stem
cells in general.
We also conducted a keyword analysis to determine changes
within the field between 2000 and 2010. Over 9,000 keywords
were associated with articles from 2000 and 15,000 with articles
from 2010– the majority of which were unrelated to the specific
types of stem cells analyzed. Only 17% and 19% respectively were
related to stem cells in general (Table 1). The percentage of
keywords related to both cancer stem cells and iPSCs saw an
increase from 3.6% to 5.9% and 0% to 0.18% respectively
(Table 1). This percentage remained relatively constant in the field
of ESCs (1.7% to 1.6%) and decreased slightly for ASCs (8.1% to
6.3%). This growth may also account for some of the large
differences in impact factors for certain journals in the dataset.
Journals likely to publish cancer stem cell research, for instance,
including Breast Cancer Research and Treatment, Journal of Clinical
Oncology, and Cancer Cell, saw large increases in impact factor.
While the United States remained the most dominate country
(with nearly 60% of total papers in both years), the most relative
growth was exhibited by Asian countries, particularly China,
whose percent of total stem cell papers examined increased from
0.41% to 4.61% (Table 3). There was also some modest relative
growth in European countries, primarily Spain (3.41 to 4.28%),
Italy (4.02 to 6.50%), the United Kingdom (9.39 to 14.6%) and
Germany (7.33 to 10.8%). And while most European countries
also saw a modest increase in their percentage of international
stem cell publications, the United Kingdom experienced more
substantial growth in this category, from 9.21% to 28.8%.
Elsewhere in the world, despite recent increased investment in
S&E research, nations in the Middle East as well as Central and
South America have yet to publish substantially in top journals
(aside from Israel).
For both 2000 and 2010, the highest number of publications
resulted from two country collaborations, with the exception of the
US-UK-Canada network in 2010 (Table 4). Many of the same
collaborations that were prolific in publishing persisted from 2000
to 2010, with the majority of these collaborations involving the
United States. In 2000, the most frequent collaborations were
between the United States and Japan, resulting in 28 publications.
While this partnership was still strong in 2010, with a total of 25
publications, both China and the United Kingdom collaborated
more frequently with the United States in 2010 with 33 and 35
publications respectively. Furthermore, it is worth noting that
while neither China nor South Korea made the top 20
collaborations list for 2000, both appeared as corresponding and
secondary authors in 2010.
Examining the list of corresponding authors from all publica-
tions, including single country publications and those resulting
from international collaborations, again saw the United States
leading (Table 5). In addition, while China only published twice in
2000 (tied for 18th out of 28 countries) as a corresponding author,
it rose to 8th in 2010 with 51 publications.
Additionally, the number of publications with five or more
different authoring countries increased from just five in 2000 (2.5%
of international publications) to 38 in 2010 (5.7% of international
collaborations). The publication featuring the largest number of
distinct countries in 2000 involved 11 different countries (France-
Australia-Belgium-Brazil-Denmark-United Kingdom-Hungary-
Italy-Netherlands-Spain-Sweden), while the publication featuring
the largest number of authoring countries in 2010 involved 15
different authors (Austria-Belgium-Czech Republic-Denmark-
United Kingdom-France-Greece-Hungary-Israel-Norway-Poland-
Portugal-Spain-Sweden-Switzerland). Consequently, while part-
nerships between two nations still dominate the number of
publications produced, it does appear that more publications are
originating from increasingly larger cross-border collaborations
involving five or more countries.
Next, the tendency of two nations to partner, whether one is a
corresponding author or both are secondary authors on a
publication, was determined. First we reviewed total partnership
based on the absolute number of publications (Figure 1).
Consistent with other results, US partnerships dominated the
top 10 from 2000 and 2010. Furthermore, all collaborative
partnership publications increased between 2000 and 2010, with
the exception of Sweden-Switzerland partnership.
Table 2. Summary of publications analyzed for 2000 and
2010.
2000 2010
Total number of publications 969 1845
Single country publications 766 1181
International publications* 203 664
Percent of international publications 20.9 36.0
Number of international partnerships** 158 381
Total number of countries in international
publications
35 47
*International publications were defined as those with authors from at least two
different countries.
**International partnerships refer to country partnerships e.g. UK and US, not
specific partnerships between lab A and lab B.
doi:10.1371/journal.pone.0073598.t002
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Finally, the tendency of two nations to partner were analyzed by
calculating a ratio of the observed to expected co-authorship
frequency, Er [8]. Positive values indicate a higher tendency to
collaborate based on both nations’ tendencies to collaborate
internationally. Of the top partnerships based on publications,
only five in 2000 and six in 2010 yielded positive values (Figure 2
and Table S4). Only two positive partnerships were present in
both years: Canada-US and Japan-US.
Overall, partnerships yielding positive values in 2000 and 2010
included: (1) countries that are geographically proximate, (2)
countries that have a history of strong political and economic ties,
or (3) partnerships in which one or both countries publish
infrequently and primarily with one other country. An example of
the third scenario is India and New Zealand, with an Er value of
46.33. Due to the nature of the equation used to calculate the
ratio, partnerships such as India and New Zealand, in which both
countries only published three times each, sharing 1 publication,
yield large positive Er values. While many of the positive and high
Er values can be explained by this phenomenon, some partner-
ships, such as the United States and Canada, the United States
and Japan, Denmark and Finland, Italy and the United Kingdom,
and Sweden and Switzerland exhibit positive Er values as these
countries are likely to have an increased tendency to collaborate.
While it is not possible to identify the exact reasons why these
nations have a higher tendency to collaborate with each other,
many of these partnerships feature countries that share geographic
borders, economic and political ties (such as joint membership in
the European Union), and or historical ties (such as the United
States and Japan from post-World War II reconstruction).
Interestingly, the partnerships resulting in the most published
papers for both 2000 and 2010, such as Germany-US, either
scored values around zero or below it (Table S4, Figure 1 and 2).
This indicates that, while these partnerships result in a high
number of absolute papers published, this high productivity does
not equate to a higher tendency for the nations to collaborate
(Figure 2). The exceptions to this, however, include the United
States with China (2.06, 5th in number of publications 2010) and
Japan (0.9, 4th in number of publications 2010). This could be due
to the growth of stem cell research in Asia. As emerging countries
invest in the necessary personnel and infrastructure for biomedical
research, it is probable that they would seek to engage in
collaborations with countries with established histories in biomed-
ical research. The overall doubling of international partnerships,
from 158 in 2000 to 381 in 2010 is also noteworthy (Table 2).
Table 3. Percentage of the total number of publications and of international publications for 2000 and 2010 by country.*{
2000 2010
% Total Papers % Intl Papers % Total Papers % Intl Papers
North America 66.4 79.3 65.6 75.9
Canada 6.71 14.8 6.50 12.8
USA 59.7 64.5 59.1 63.1
Asia 11.6 24.15 18.6 28.6
China 0.41 0.99 4.61 7.22
India 0.31 0.49 0.16 0.15
Japan 10.0 20.7 9.05 11.6
Singapore 0.21 0.49 1.79 4.22
South Korea 0.31 1.48 2.11 3.77
Taiwan 0.31 0 0.87 1.66
Europe 36.0 72.2 48.3 96.4
France 8.36 19.2 6.99 13.4
Germany 7.33 19.2 10.8 22.6
Italy 4.02 9.36 6.50 11.9
Netherlands 3.51 9.85 5.14 10.5
Spain 3.41 5.42 4.28 9.19
United Kingdom 9.39 9.21 14.6 28.8
Middle East 1.55 4.93 3.60 4.52
Israel 1.55 4.93 3.47 3.92
Iran 0 0 0.16 0.15
Lebanon 0 0 ,0.01 0.15
Saudi Arabia 0 0 0.11 0.3
Latin America 0.52 1.47 0.38 1.20
Brazil 0.10 0.49 0.38 1.05
Chile 0.21 0.49 ,0.01 0.15
Mexico 0.21 0.99 0 0
*Only countries with a strong history of biomedical research or are relatively new entrants were selected for the table.
{Regional percentages (1) only take into account the countries represented in the table, and (2) sum to over 100%, as publications often have multiple authors. For
example, a publication with authors in US, China and UK would be represented in all three countries.
doi:10.1371/journal.pone.0073598.t003
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Discussion
As S&E research globalizes, it is increasingly important to
understand the exact nature of international connections. Previous
scholarship has demonstrated that one of the benefits resulting
from international, collaborative research is a higher citation rate
than work produced by scientists working at a single institution or
within a single country [2–5]. Many possible explanations for this
phenomenon, including the sharing of resources, ideas, and
expertise, have been proposed. While it has also been suggested
that increased collaboration lends to a larger number of self-
citations, thus inflating citation rates, studies have indicated that
this alone cannot explain the higher citation rates resulting from
international collaborations [31–34]. Furthermore, the proportion
of self-citations has remained relatively stable, around 10% of
publications in the natural sciences, while the rate of international
collaborations has increased, demonstrating the benefit of
international collaborations in this area of research [14].
This study examined whether more countries were engaging in
international collaborative research efforts or whether research
primarily remained within national borders by mapping collabo-
rative partnerships in the area of stem cell research. Stem cell
research provided an ideal area of study due to its international
nature and the existence of diverse national policies ranging from
prohibitive to liberal [23]. And the promise of stem cell therapies
for debilitating diseases such as macular degeneration, diabetes,
and Parkinson’s disease has convinced many countries to embrace
this area of research [35]. Indeed, from 2007–2011, the number of
original research papers utilizing stem cells has more than
doubled, demonstrating a growing global interest in this area [17].
From an analysis of 2,814 publications from 2000 and 2010, the
United States was identified as the most prolific country in the field
– accounting for nearly 60% of the articles from both years. While
many emerging economies investing in S&E, including those in the
Middle East and South America, have yet to become a substantial
presence in the global stem cell research arena, this study indicates
that Asian countries are publishing an increasing proportion of
stem cell papers in top journals. This section will highlight three
major themes. First, we will examine the growth of stem cell
research in Asia, specifically in China. Then, we will discuss the
continuing dominance of the United States and Europe in
publications in high impact journals. Finally, we will comment
on the persistence of traditional collaborative networks amidst the
globalization of stem cell science.
Stem Cell Research Leaders in Asia
Asia has exhibited the largest relative growth in this area of
research between 2000 and 2010, with China playing a significant
role (Table 2). The percentage of Chinese-authored stem cell
papers in the top 50 journals grew more than ten-fold, while the
Table 4. Top 20 collaborations by publication for 2000 and 2010.
2000 # of Papers 2010 # of Papers
USA*-Japan 18 USA*-China 26
Japan*-USA 10 USA*-United Kingdom 20
Germany*-USA 9 United Kingdom*-USA 15
Canada*-USA 8 USA*-Canada 15
Italy*-USA 8 USA*-Germany 15
USA*-Canada 8 USA*-Japan 13
USA*-Germany 7 Japan*-USA 12
Germany*-France 6 Canada*-USA 10
Italy*-United Kingdom 6 France*-USA 9
USA*-France 6 Italy*-USA 9
USA*-United Kingdom 6 USA*-Italy 8
France*-United Kingdom 5 Australia*-USA 7
France*-USA 5 China*-USA 7
Israel*-USA 5 Germany*-USA 7
Netherlands*-USA 5 USA*-Canada-United Kingdom 7
United Kingdom*-USA 5 USA*-France 7
USA*-Spain 5 USA*-Netherlands 7
Germany*-Spain 4 USA*-South Korea 7
Italy*-Germany 4 USA*-Spain 7
Netherlands*-Spain 4 South Korea*-USA 6
Netherlands*-United Kingdom 4 Spain*-United Kingdom 6
Sweden*-Switzerland 4 Spain*-USA 6
United Kingdom*-USA 4 USA*-Taiwan 6
United Kingdom*-Germany 4
USA*-Netherlands 4
USA*-Switzerland 4
*country with corresponding author.
doi:10.1371/journal.pone.0073598.t004
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percent of Chinese-authored international papers increased over
seven times from 2000 to 2010. In contrast, relative growth rates in
the United States, Canada and European countries remained
more modest, with the exception of the United Kingdom, which
saw more substantial increases, particularly in its share of
international publications.
These trends are congruent with the general trends in S&E
article output [36]. The number of publications worldwide
increased at an annual rate of 2.6% between 1999 and 2009,
with the highest average annual rates from Asian countries
including China (16% annual increase), as opposed to the United
States (1% annual increase) [36]. Consequently, in 2007, China
surpassed the United Kingdom, Germany, and Japan to become
the world’s second most prolific producer of publications, up from
14th place in 1995 [36].
This phenomenon is consistent in stem cell publications from
2010 if all the publications are examined (Table S3). However,
when only publications from the top 50 journals are considered,
China still lags behind the United States, Canada, Japan, and
European nations. While China produced 11.7% of all stem cell
publications, it authored only 4.6% of publications in the top 50
journals. This indicates that while S&E research is growingly
rapidly in China, much of the research has yet to translate into
publications in high impact journals.
These increased publication rates are likely the result of recent
growth in research and development (R&D) expenditures in Asian
countries coupled with their permissive approaches to stem cell
research. In the past decade, R&D expenditures have increased
most dramatically in China, averaging about 19% annually,
placing China third with 9% of the world’s R&D expenditures
[36]. The ratio of R&D to GDP has also increased substantially
during this time period for China. China’s ratio remains low, at
1.7%, but this number has more than doubled from 0.8% in 1999
[36].
Stem cell research in particular has enjoyed immense govern-
mental support in China under the Ministry of Science and
Technology’s (MOST) 1986 applied research initiative and its
1997 basic research program, known as the 863 and 973 plans,
respectively (http://program.most.gov.cn). One factor that many
researchers have identified as propelling China’s stem cell research
forward is its permissive stem cell regulations [24,37–40].
Therapeutic cloning, the use of surplus embryos from abortions,
and the use of embryos created from somatic cell nuclear transfer,
are all permitted [24]. In 2003, in response to concerns that more
specific regulation was needed to oversee the growing area of
research in China, the Ministry of Health and MOST jointly
supported the ‘Ethical Guiding Principles on Human Embryonic
Stem Cell Research’, which highlights the principles of respect for
human life, informed consent, and safety [41]. The document
proposes standardized procedures, institutional review boards, and
professional qualifications for those working in the field of human
ESC research, and it also bans any form of embryo or fetal tissue
trade [41]. While these trends are promising, many safety and
ethical concerns remain, particularly with regards to the safety of
currently offered stem cell therapies [25].
United States and Europe Retain their Dominance in Top
Journals
While the relative growth rates in the number of publications
from the United States were much lower than those in Asian
countries, US S&E publications still remain some of the most
cited worldwide. But in the decade between 1998 and 2008, the
total share of the United States’ citations decreased from 45%
to 36% [42]. Yet, the percentage of US-authored articles with
the highest number of citations and appearing in top journals
has remained relatively constant. The index of highly cited
articles declined slightly from 1998 and 2008 from 1.83 to 1.78,
but is still well above the expected index value of 1 (indexes of
the European Union, China, and Japan are all below one) [36].
In 2010, while US articles were 28% of all articles in the cited
period, they represented 49% of the top 1% of all cited articles
[42]. And US authors were cited 76% more frequently than
expected based on their percentage of publications worldwide in
2010 [42]. And in terms of R&D expenditures, the United
States still leads the field, accounting for 31% of worldwide
research expenditures [36].
This phenomenon is also evident in stem cell science. While
the United States accounts for 40% of all stem cell publications
in 2010 (down from about 43% in 2000 and 50% in 1995), it is
responsible for nearly 60% of the papers analyzed from the top
50 journals by impact factor in 2010 (Table S3). Admittedly,
some of this dominance in high impact journals may be the
result of a familiarity with publication criteria and procedures,
Table 5. List of corresponding author countries for 2000 and
2010.
2000 # of Papers 2010 # of Papers
USA 505 USA 911
Japan 64 United Kingdom 145
United Kingdom 57 Japan 115
France 48 Germany 100
Canada 43 France 77
Germany 40 Italy 71
Italy 27 Canada 65
Netherlands 19 China 51
Australia 14 Netherlands 45
Spain 13 Spain 39
Israel 10 Australia 38
Switzerland 9 Switzerland 30
Austria 8 South Korea 24
Sweden 8 Sweden 24
Belgium 7 Belgium 22
Finland 3 Israel 19
Taiwan 3 Austria 15
China 2 Singapore 14
Denmark 2 Denmark 9
India 2 Taiwan 7
Brazil 1 Greece 4
Chile 1 India 3
Ireland 1 Ireland 3
Mexico 1 Czech Republic 3
Norway 1 Finland 2
Russia 1 Iran 2
Singapore 1 Norway 2
South Korea 1 Portugal 2
Lebanon 1
New Zealand 1
Poland 1
doi:10.1371/journal.pone.0073598.t005
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as well as more established reputations of researchers in the
United States. However, the peer review process for top
journals remains rigorous, thus reinforcing the prominence of
US publications.
Like the United States, the European Union’s share of S&E
publications decreased in the past decade; however, European
authors have improved on citations per publication. According to
the US National Science and Engineering Indicators, EU
authored articles are cited less frequently than expected, although
this measurement is improving from 27% less frequently in 2000
to only 6% less frequently in 2010 [43]. In stem cell research,
European countries are still well represented in top journals. From
2000 to 2010, Germany, Italy, Netherlands, Spain and the United
Kingdom all exhibited a relative increase of around 2–5% in their
share of total stem cell publications. Furthermore, many of these
European countries exhibited an even larger relative growth in
percent of international publications, particularly the United
Kingdom from 9.21 to 28.8%. Furthermore, France (4.9% of total
publications, 7% of publications from top 50 journals), Germany
(9.9%, 11%), Italy (5.7%, 6.5%), Netherlands (3.1%, 5.1%),
Spain (3%, 4.3%), and the United Kingdom (7%, 14.6%) all
have a higher percentage of publications in the top 50 journals
analyzed than in the entire population of stem cell journals for
2010. These nations, thus, all produce a higher proportion of high
impact publications relative to their proportion of all stem cell
publications.
Traditional Networks of Collaboration Remain Dominant
Amidst Globalization
Examination of the top 20 collaborations, top 20 partnerships,
and the country partnerships with a positive ratio of observed-to-
expected co-authorship frequency (Er) reveals that collaborative
partnerships correlate most strongly with traditional factors
including geographic proximity (neighboring nations or those in
the same regional supranational organizations), similarity in
cultural practices and language, availability of funding, and shared
histories amongst others (Table 3, Table S4, Figure 1 and
Figure 2).
All the top 20 collaborations in 2000 involved either: (1)
European nations, (2) United States and European nations, (3)
Canada and European nations, (4) United States and Japan, (5)
United States and Canada, or (6) United States and Israel
(Table 3). The top 20 collaborations in 2010 also exhibited similar
tendencies, with the United States involved in all of the top 20
collaborations.
The only difference between the 2000 and 2010 datasets was
the appearance of collaborations between the United States and
China, as well as the United States and South Korea in 2010.
These collaborations could have evolved for multiple reasons, with
the likely rationale the large investments in research made by both
China and South Korea. China has employed many programs
attracting Chinese national scientists who trained in the United
States [43]. Those who do return to China and establish
laboratories bring with them, across the Pacific, relationships with
Figure 1. Top Collaborative Partnerships Based on Absolute Publication Counts. The top 15 collaborative partnerships were determined
for each two-country pair in 2000 (dark blue) and 2010 (light blue). Ten partnerships rated high in both years: Canada-USA, France-Germany, France-
UK, France-USA, Germany-UK, Germany-USA, Italy-USA, Japan-USA, Spain-USA, UK-USA. Overall, the number of publication increased for all top pairs
with the exceptions of Sweden-Switzerland.
doi:10.1371/journal.pone.0073598.g001
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American researchers. This phenomenon also likely explains the
wide range of institutions with which Chinese researchers
collaborate, ranging from universities to private corporations.
Analyzing the Chinese institutions with the highest number of
international publications in 2010 and their partner institutions,
no particular partnership appeared more than a handful of times.
The increased tendency for China and the United States to
collaborate is further supported by the highest positive (2.1) ratio of
observed-to-expected co-authorship frequency (Er) among the top
partnerships for both 2000 and 2010 (Figures 1 and 2). It was one
of only four partnerships that exhibited a shift, from 2000 to 2010,
from a negative or zero Er value to a positive one. The other three
partnerships include Germany-UK, Spain-UK, and UK-US. This
increased tendency between European nations to collaborate
could be the result of European Union related research programs.
In 2000, the European Union established the European Research
Area to unify research efforts among its members [44]. And under
both its Sixth and Seventh Framework Programs, covering 2002–
2013, a large portion of EU research funding specifically targets
collaborative projects [45].
The increased tendency for the United Kingdom to collaborate
internationally is also likely a result of various national initiatives,
recognizing the importance of international collaboration and
knowledge sharing, undertaken in the past decade. Some examples
of these initiatives include the establishment of the International
Stem Cell Forum (ISCF) by the UK Medical Research Council
(MRC) along with eight other international funding agencies in
2003 to encourage international collaboration and funding efforts
[46]. In 2008, the International Stem Cell Banking Initiative, led
by the UK Stem Cell Bank to develop a global network of existing
banks, was inaugurated [47]. Also in that year, the United
Kingdom announced international collaborations with the Cali-
fornia Institute for Regenerative Medicine (CIRM) with the focus
of advancing stem cell therapies [48].
Due to the controversial nature of stem cell research,
particularly human ESC research, the regulatory approaches
taken by individual countries vary greatly and differ in degree from
highly restrictive to highly permissive. Applying the definitions of
restrictive, intermediate, and liberal stem cell policies from Isasi
and Knoppers, no salient patterns can be observed between the
top 20 collaborations or partnerships with their national stem cell
policies [49]. All policy combinations–restrictive-restrictive, re-
strictive-intermediate, restrictive-liberal, intermediate-intermedi-
ate, intermediate-liberal, and liberal-liberal–can be found. This
is consistent with other recent studies examining the use of human
ESC lines in international research under differing policy regimes.
These studies have concluded that innovation driven rather than
policy driven considerations have been most influential in the
decision to use various human ESC lines [50,51].
It is important to emphasize that this study does not try to prove
any type of causal relationship between various factors such as
policy, geography, economic ties, shared histories, and cultural
similarities with the formation of research collaborations. Many
factors influence research patterns, and it is interesting to examine
any correlations between these factors and the extant patterns in
collaboration; however, no causation is implied by the study.
Figure 2. Observed Versus Expected Collaboration Patterns. The tendency of two nations to collaborate was determined by calculating a
ratio of the observed to expected co-authorship frequency. A positive number illustrates unusually high tendency between two countries to
collaborate with each other – in the context of their collaborations with other countries and the entire pool of collaborations– and a negative number
reflects a lower than expected collaboration rate. The ratios from 2000 (dark blue) and 2010 (light blue) for top collaborative partnerships that existed
both years and exhibited a positive value in one or both years are shown alongside each other.
doi:10.1371/journal.pone.0073598.g002
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Conclusion
Scientists decide to collaborate internationally for various
reasons, and multiple factors play a role in their decision. The
availability of a cell line, funding opportunities, prior collaborative
or personal experiences, institutional partnerships, geographic
proximity, language, and cultural similarities are just some of the
possible factors. As a study examining the broader trends in the
evolution of international collaborative research networks, this
study cannot provide a detailed examination into the nature and
rationale for each collaborative effort.
Furthermore, journal requirements also vary greatly in their
definition of authorship, thus some listed authors/collaborators
may only have played a very small role in the research, such as
sharing a biological reagent or editing the final paper, while others
may have been more involved. This study, thus, is also unable to
identify the degree to which nations are collaborating. And while
the increased prevalence of cancer stem cell and iPSC research
may admittedly skew the countries publishing in the top 50
journals, as certain countries may have more programs invested in
these areas (e.g. Japan and iPSCs), further analysis in the future
will be required to measure the extent of the skew, if any exists.
Further research is also required to better quantify the benefits of
participating in an international research network from a citation
perspective. This will contribute to our understanding of the
motivations for engaging in international collaborations, the
rationales behind selecting collaborators, and the extent and
nature of international collaborations in an effort to promote more
cross-border knowledge sharing and research pursuits.
Regardless, this study is among the first of its kind to examine
the global networks of collaboration and their evolution in stem
cell science. We found that over the past decade, collaborative
relationships have increased, both in absolute number of
publications and as a percentage of total stem cell publications,
involving scientists from 47 nations (up from 28).
While scientists in North America and Europe, with strong
traditions of biomedical research, continue to command a large
percentage of publications in high impact journals, more recent
entrants to the field, particularly those from Asian countries, are
beginning to gain a larger portion of these publications. They have
done so not only by increasing their investment in R&D and
supporting internal research efforts, but also by reaching out to the
international community and establishing partnerships with
scientists and institutions from other nations. We believe that this
trend will persist in the future, evident from the many partnerships
from publications from 2010 that were not present from an
examination of publications from 2000. This development could
potentially lead to increased relationship building with new
partners in regions such as Latin America and the Middle East,
which are just beginning to encourage stem cell research. As stem
cell research continues to grow as a highly collaborative field of
research, it will likely provide more insight on cross-border
collaboration in research and call for increased international stem
cell policy regimes to facilitate future collaborations.
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